TITLE

Inhaled corticosteroids were safely stepped down in chronic, stable asthma: COMMENTARY

AUTHOR(S)
Peters, Jay I.
PUB. DATE
January 2004
SOURCE
ACP Journal Club;Jan/Feb2004, Vol. 140 Issue 1, p14
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This article focuses on a study regarding the use of inhaled corticosteroids in asthma patients, published in the 2003 issue of "British Medical Journal." The dose-response curve for inhaled corticosteroids is relatively flat, with most of the benefit on commonly measured outcomes occurring at lower doses. This study showed that a substantial proportion of patients with chronic asthma could reduce their dose of inhaled corticosteroids by 50% without increasing either symptoms or exacerbations. One of the limitations of the study was that participants were advised to use their reliever inhaler on a regular basis. This study showed that a step-down strategy can be used in patients with moderate or severe disease without compromising asthma control.
ACCESSION #
12104549

 

Related Articles

  • Inhaled corticosteroids were safely stepped down in chronic, stable asthma.  // ACP Journal Club;Jan/Feb2004, Vol. 140 Issue 1, p14 

    This article focuses on a study regarding the use of inhaled corticosteroids in asthma patients, published in the 2003 issue of "British Medical Journal." For this study a clinical trial of 259 patients was conducted. Patients were allocated to a step-down group or a control group. All patients...

  • APRECIERI ASUPRA EFECTELOR ADVERSE ALE CORTICOSTEROIZILOR INHALATORI ADMINISTRAÅ¢I ÃŽN DOZE MICI LA COPIII ASTMATICI. MOHOR, C. // Acta Medica Transilvanica;dec2012, Vol. 17 Issue 4, p103 

    The way in which inhaled corticosteroids influence the growth and the development of the children with asthma is relatively little studied, the results being often contradictory. The study was conducted on two hundred subjects with one hundred children with asthma treated with inhaled...

  • Salmeterol (Serevent) asthma trial halted early. Wooltorton, Eric // CMAJ: Canadian Medical Association Journal;3/18/2003, Vol. 168 Issue 6, p738 

    Discusses the concerns that the drug Serevent might be associated with life-threatening asthma episodes and asthma-related deaths. Controversy about the safety of long-acting Î’-receptor agonists (LABA); Assessment of white and black patients who used inhaled corticosteroids at baseline;...

  • When can personal best peak flow be determined for asthma action plans? Reddel, H. K.; Marks, G. B.; Jenkins, C. R. // Thorax;Nov2004, Vol. 59 Issue 11, p922 

    Background: Written asthma action plans based on personal best peak expiratory flow (PEF) consistently improve health outcomes, whereas those based on predicted PEF do not. Guidelines state that personal best PEF should be assessed over 2-3 weeks during good asthma control, but it is unclear how...

  • Long-term Follow-up of Pulmonary Function in Bronchial Asthma Patients Treated with Pranlukast. Yanagawa, H.; Sugita, A.; Azuma, M.; Ogawa, H.; Kitamuro, C.; Yoneda, K.; Shinkawa, K.; Tani, K.; Sone, S. // Lung;2004, Vol. 182 Issue 1, p51 

    Clinical studies have shown that pranlukast, a selective cysteinyl leukotriene antagonist, is effective for bronchial asthma. In the present paper, we retrospectively analyzed long-term asthma control by pranlukast treatment in patients treated with inhaled corticosteroids. We analyzed medical...

  • Outcomes in Clinical Trials of Inhaled Corticosteroids for Children with Asthma Are Narrowly Focussed on Short Term Disease Activity. Sinha, Ian P.; Williamson, Paula R.; Smyth, Rosalind L. // PLoS ONE;2009, Vol. 4 Issue 7, p1 

    Background: Little work has been done to determine which outcomes should be measured in randomised controlled trials (RCTs) in children with asthma. Drug regulatory authorities require that short term disease activity is measured, but other outcome domains are not mandatory for licensing and...

  • Beclazone Easi-Breathe.  // Royal Society of Medicine: Medicines;2002, p100 

    The article presents information on beclazone easi-breathe, a proprietary, prescription-only preparation of the corticosteroid beclometasone dipropionate. It can be used to prevent asthma attacks and is available in forms for aerosol inhalation with breath-actuated units.

  • The use of corticosteroids in patients with COPD or asthma does not decrease lung squamous cell carcinoma. Zhi-Hong Jian; Jing-Yang Huang; Frank Cheau-Feng Lin; Oswald Ndi Nfor; Kai-Ming Jhang; Wen-Yuan Ku; Chien-Chang Ho; Chia-Chi Lung; Hui-Hsien Pan; Yu-Chiu Liang; Ming-Fang Wu; Yung-Po Liaw; Jian, Zhi-Hong; Huang, Jing-Yang; Lin, Frank Cheau-Feng; Nfor, Oswald Ndi; Jhang, Kai-Ming; Ku, Wen-Yuan; Ho, Chien-Chang; Lung, Chia-Chi // BMC Pulmonary Medicine;12/3/2015, Vol. 15, p1 

    Background: Asthma and COPD (chronic obstructive pulmonary disease) lead to persistent airway inflammation and are associated with lung cancer. The objective of the study was to assess the relationship between inhaled (ICS) and oral corticosteroid (OCS) use, and risk of lung...

  • asthma.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p202 

    A definition of term "asthma" is presented. It refers to a disease caused by increase responsiveness of the tracheobronchial tree to stimuli, that results in episodic narrowing and inflammation of the airways. The etiology and treatment for the condition are discussed, including beta-2 agonists,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics